	Adjuvant Pembrolizumab for Stage IIB or IIC Melanoma: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open Leachman SA, Luke JJ, Ascierto PA, Long GV, Khattak MA, Rutkowski P, Xu ZJ, Fukunaga-Kalabis M, Krepler C, Eggermont AMM, Schadendorf D. PMID: 41701495 [PubMed - indexed for MEDLINE]
	Verhoeff-van Gieson May Distinguish Desmoplastic Melanoma From Re-Excision Scar. Am J Dermatopathol Kiszluk A, Alhalaseh YN, Asar MC, Chen F, Speiser JJ. PMID: 41700577 [PubMed - indexed for MEDLINE]
	A Systematic Review and Meta-Analysis of the Efficacy and Safety of Propranolol Versus Other Drugs in the Treatment of Infantile Hemangioma. J Cosmet Dermatol Hu J, Pan L, Kong H, Lou J. PMID: 41700540 [PubMed - indexed for MEDLINE]
	Epigenetic activation of SLC7A11 defines a ferroptosis-immune axis and enables robust DNA methylation-based diagnosis of lung squamous cell carcinoma. PeerJ Lu HP, Nong K, Pang L, Tang Y, Li Q, Chen Z, Xiao L, Zhu L, Li D, Chen Y, Chen G, Ling J, Li J, Chen G, Dang YW. PMID: 41700135 [PubMed - indexed for MEDLINE]
	LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trial. Nat Commun Hamid O, Ekström-Rydén V, Mehmi I, Wang D, Patel M, Alsaqal S, Irenaeus S, Nordström C, Sandin LC, Grauers Wiktorin H, Lövgren T, Eriksson E, Leja-Jarblad J, Loskog A, Ullenhag GJ. PMID: 41698954 [PubMed - as supplied by publisher]
	Ultrasonic manifestation of dermatofibrosarcoma protuberans and differential diagnosis from superficial venous malformation: A retrospective study. J Int Med Res Zhuang N, Yi Z, Ma E, Yin R, Zhang Y, Zhao C, Lv H, Xie L, Tian Y, Liao M, Liu H, Sun D, Li T, Wang F, Xie H. PMID: 41698654 [PubMed - indexed for MEDLINE]
	Vibostolimab coformulated with pembrolizumab versus pembrolizumab alone as adjuvant therapy for high-risk stage IIB-IV melanoma (KEYVIBE-010): a randomised, double-blind, phase 3 study. Lancet Oncol Dummer R, Guo J, Luke JJ, Carlino MS, Schadendorf D, Khattak MA, Hauschild A, Ascierto PA, Chen Y, Shin SJ, Rutkowski P, Luo Z, Chen J, Rivalland G, Coetzee C, Ribas A, Mujika K, Markel G, Villarroel RU, Dizdar O, Caglevic C, Grebennik D, Donovan K, Krepler C, Long GV. PMID: 41698381 [PubMed - as supplied by publisher]
	Modern Management of Newly Diagnosed Vulvovaginal Melanoma. J Natl Compr Canc Netw Leitao MM Jr. PMID: 41698346 [PubMed - as supplied by publisher]
	Non-coding RNA transcripts and their exosomal counterparts in the pathogenesis, diagnosis, and treatment of skin cancers, with a focus on melanoma. Front Mol Biosci Zou L, Wen X, Dai X, Wu Y. PMID: 41696579 [PubMed]
	A bibliometric systematic review of extracellular vesicles in cutaneous malignant melanoma from 2005 to 2025. Front Oncol Christodoulides N, Bollard S, Chabria Y, O'Driscoll L, Potter S. PMID: 41695369 [PubMed]
	Commentary: Evaluating the efficacy and safety of tebentafusp in the treatment of metastatic uveal melanoma: a 2025 update systematic review and meta-analysis. Front Oncol Maselli-Schoueri JH, Saibil SD. PMID: 41695325 [PubMed]
	A combination of low TMB and PD-L1 expression predict poor progression-free survival of metastatic melanoma patients treated with first-line ipilimumab plus nivolumab. Front Immunol Akhavan B, Samlowski W. PMID: 41694351 [PubMed - indexed for MEDLINE]
	Data-driven strategies for immunoradiotherapy in uveal melanoma: the role of artificial intelligence. Front Pharmacol Gu D, Feng Y, Li H. PMID: 41693780 [PubMed]
	Metastatic melanoma of unknown primary: an unusual dermatologic presentation. BMJ Case Rep Morrissette K, Chen R, Cater S, Boswell E, Pavlis M. PMID: 41692483 [PubMed - indexed for MEDLINE]
	Multi-omic biomarker detection in UV-induced melanoma. Clin Chim Acta Alqahtani SM, Afzal M, Afzal O, Alabbas A, Phalak P, Goyal K. PMID: 41692134 [PubMed - as supplied by publisher]
	Determinants of adjuvant treatment choice between immunotherapy (immune checkpoint inhibitor) and targeted therapy in resected stage III BRAF V600-mutated cutaneous melanoma: a multicenter observational study: MELADJ3. Melanoma Res Devoldere A, Bouche O, Barbe C, Didier K, Colbach S, Brocard FG, Carlier C. PMID: 41691529 [PubMed - as supplied by publisher]
	Parkinson's disease and risk of melanoma in United States Veterans: A Veterans Affairs Cancer Registry retrospective cohort study. J Am Acad Dermatol Hwang JC, Huhmann LB, Perez D, Kim DY, Nannini K, Do NV, Gaziano JM, Brophy MT, Wheless LE, Fillmore NR, Hartman RI. PMID: 41690486 [PubMed - as supplied by publisher]
	Validation and clinical utility of predictive nomograms for sentinel node positivity in cutaneous malignant melanoma in Ireland. Surgeon Christodoulides N, Quirke N, Leon R, Ghinis A, Jeantet Q, Potter S. PMID: 41688298 [PubMed - as supplied by publisher]
	Multi-Institutional Study Evaluating the Role of Early Circulating Tumor DNA Dynamics During Treatment With Immune Checkpoint Inhibitors in Patients With Advanced-Stage Melanoma. JCO Precis Oncol Ma VT, Zhou AY, Forati A, Hollnagel F, Patel JD, Burkey C, Steimle A, Sahasrabudhe DM, Mannino MC, Schehr JL, Birbrair A, Zhao SG, Lang JM, Victor AI. PMID: 41687044 [PubMed - indexed for MEDLINE]
	Potential mechanisms of Si-Wu-Tang against esophageal squamous cell carcinoma: A machine learning pharmacological study. Medicine (Baltimore) Li X, Zhang C, Li J, Yuan J, Xing T, Yang H, Shi H. PMID: 41686584 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 141442

Page 1 of 7073



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy